Concepedia

Martin Kindermans

MK

Statistics

Publications

3

Citations

307

H-Index

3

Active since

2019

Affiliations

Inserm(Current)

Institut Cochin

TUM Klinikum

Helmholtz Zentrum München

ImCyse (Belgium)

Martin Kindermans is an author at Inserm specializing in life sciences, autoimmune diseases, and diabetes management.

ORCID

Publications per year

2019–2024

3

Publications

3

A Pan-cancer Transcriptome Analysis Reveals Pervasive Regulation through Alternative Promoters

Deniz Demircioğlu, Engin Cukuroglu, Martin Kindermans et al. · Cell · 2019 · 264 citations · Full text

, , +12

First-in-human, double-blind, randomized phase 1b study of peptide immunotherapy IMCY-0098 in new-onset type 1 diabetes

Jean Van Rampelbergh, Peter Achenbach, Richard David Leslie et al. · BMC Medicine · 2023 · 27 citations · Full text

, , +17

First-in-human, double-blind, randomized phase 1b study of peptide immunotherapy IMCY-0098 in new-onset type 1 diabetes: an exploratory analysis of immune biomarkers

Jean Van Rampelbergh, Peter Achenbach, Richard David Leslie et al. · BMC Medicine · 2024 · 16 citations · Full text

, , +17

1–3 of 3